Postpartum hemorrhage: Evidence-based medical interventions for prevention and treatment

Clinical Obstetrics and Gynecology

Volumn 53, Issue 1, 2010, Pages 165-181

  Rajan, Priya V ^a   Wing, Deborah A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ergot alkaloids; Misoprostol; Oxytocin; Postpartum hemorrhage; Third stage of labor; Uterotonic

Indexed keywords

ANESTHETIC AGENT; CARBETOCIN; ERGOMETRINE; ERGOMETRINE PLUS OXYTOCIN; ERGOT ALKALOID; MAGNESIUM SULFATE; METHYLERGOMETRINE; MISOPROSTOL; NIFEDIPINE; OXYTOCIN; PLACEBO; PROSTAGLANDIN E; PROSTAGLANDIN F; PROSTAGLANDIN F2 ALPHA; SULPROSTONE;

ARTIFICIAL EMBOLISM; BLEEDING; BLOOD PRESSURE; BLOOD TRANSFUSION; DELIVERY; DRUG BIOAVAILABILITY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FEVER; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; LABOR; MATERNAL MORBIDITY; MATERNAL MORTALITY; NAUSEA; NAUSEA AND VOMITING; POSTPARTUM HEMORRHAGE; PREVALENCE; REVIEW; SHIVERING; SIDE EFFECT; SURGICAL TAMPON; UTERINE ATONY; UTERUS CONTRACTION; VOMITING;

BLOOD TRANSFUSION; ERGOT ALKALOIDS; FEMALE; HEMOSTATIC TECHNIQUES; HUMANS; LABOR STAGE, THIRD; MISOPROSTOL; OXYTOCICS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 77049083888     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181ce0965     Document Type: Review

References (84)

1. Francois K, Foley M. Antepartum and Postpartum Hemorrhage. In: Gabbe S, Niebyl J, Simpson J. Obstetrics: Normal and Problem Pregnancies. 5th ed. Philadelphia, PA: Elsevier; 2007: 456-485.
2. Pritchard J. Changes in blood volume during pregnancy and delivery. Anesthesiology. 1965;26:393-399.
3. Stafford I, Dildy G, Clark S, et al. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am JObstetGynecol. 2008;199:519.e1-519.e7.
4. Patel A, Goudar S, Geller S, et al. Drape estimation versus visual assessment for estimating postpartum hemorrhage. Int J Gyn Obstet. 2006;93:220-224.
5. Larsson C, Saltvedt S, Wiklund I, et al. Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration. Acta Obstet Gynecol Scand. 2006;85: 1448-1452.
6. Dildy G, Paine A, George N, et al. Estimating blood loss: can teaching significantly improve clinical estimation? Obstet Gynecol 2004;104:601-606.
7. Maslovitz S, Barkai G, Lessing J, et al. Improved accuracy of postpartum blood loss estimation as assessed by simulation. Acta Obstet Gynecol Scand. 2008;87: 929-934.
8. ACOG Practice Bulletin No. 76: Postpartum Hemorrhage. Obstet Gynecol. 2006; 108:1039-1047.
9. Clark S, Yeh S, Phelan J, et al. Emergency hysterectomy for obstetric hemorrhage. Obstet Gynecol. 1984;64:376-380.
10. Khan K, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367: 1066-1074.
11. Mbonye A, Asimwe J, Kabarangira J, et al. Emergency obstetric care as the priority intervention to reduce maternal mortality in Uganda. Int J Gynaecol Obstet. 2007;96:220-225.
12. Carroli G, Cuesta C, Abalos E. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008;22:999-1012.
13. Walraven G, Wanyonyi S, Stones W. Management of post-partum hemorrhage in low-income countries. Best Pract Res Clin Obstet Gynaecol. 2008;22: 1013-1023.
14. International Confederation of Midwives and International Federation of Gynaecologists andObstetricians (FIGO). Joint Statement: management of the third stage of labour to prevent post-partum haemorrhage. Maternal and Child Health. 2004;49:76-77.
15. Hofmeyr GJ, Abdel-Aleem H, Abdel- Aleem M. Uterine massage for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews. 2008; 3:CD006431.
16. Prendiville W, Harding J, Elbourne D, et al. The Bristol third stage trial: active versus physiological management of third stage of labour. BMJ. 1988:297; 1295-1300.
17. Rogers J, Wood J, McCandlish R, et al. Active versus expectant management of third stage of labour: the Hinchingbrooke randomised controlled trial. Lancet. 1998;351:693-699. (Pubitemid 28105338)
18. Prendiville W, Elbourne D,McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database of Systematic Reviews. 2000; 3.
19. Jackson K, Allbert J, Schemmer G, et al. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol. 2001;185:873-877.
20. Huh W, Chelmow D,Malone F.Adoubleblinded randomized controlled trial of oxytocin at the beginning versus the end of the third stage of labor for prevention of postpartum hemorrhage. Gynecol Obstet Invest. 2004;58:72-76.
21. Abdel-Aleem H, Hofmeyr GJ, ShokryM, et al. Uterine massage and postpartum blood loss. Int J Gynecol Obstet. 2006; 93:238-239.
22. WHO Recommendations for the Prevention of Postpartum Hemorrhage, 2007.
23. Winter C, Macfarlane A, Deneux- Tharaux C, et al. Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG. 2007;114:845-854.
24. Cotter AM, Ness A, Tolosa JE. Prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2001;4.
25. Orji E, Agwu F, Loto O, et al. A randomized comparative study of prophylactic oxytocin versus ergometrine in the third stage of labor. Int J Gynecol Obstet. 2008;101:129-132.
26. Saito K, Haruki A, Ishikawa H, et al. Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage. J Obstet Gynaecol Res. 2007;33:254-258.
27. Fujimoto M, Takeuchi K, Sugimoto M, et al. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor. Acta Obstet Gynecol Scand. 2006;85:1310-1314.
28. Tsu V, Sutant A, Vaidya K, et al. Oxytocin in prefilled Uniject injection devices for managing third-stage labor in Indonesia. Int J Gynecol Obstet. 2003;83: 103-111.
29. Strand R, Da Silva F, Jangsten E, et al. Postpartum hemorrhage: a prospective, comparative study in Angola using a new disposable device for oxytocin administration. Acta Obstet Gynecol Scand. 2005; 84:260-265.
30. Breathnach F, Geary M. Uterine atony: definition, prevention, nonsurgical management, and uterine tamponade. Semin Perinatol. 2009;33:82-87.
31. Liabsuetrakul T, Choobun T, Peeyananjarassri K, et al. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database of Systematic Reviews 2007;2.
32. De Groot A, Van Roosmalen J, Van Dongen P, et al. A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage. Acta Obstet Gynecol Scand. 1996;75:464-468.
33. McDonald SJ, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews. 2004;1.
34. Dansereau J, Joshi AK, Helewa ME, et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol. 1999;180:670-676.
35. Boucher M, Horbay G, Griffin P, et al. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section. J Perinatol 1998;18:202-207.
36. Boucher M,Nimrod CA, Tawagi GF, etal. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery: a doubleblind randomized trial. J Obstet Gynaecol Can. 2004;26:481-488.
37. Leung SW, Ng PS, Wong WY, et al. A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour. BJOG 2006;113: 1459-1464.
38. Nirmala K, Zainuddin AA, Ghani NA, et al. Carbetocin versus syntometrine in prevention of post-partum hemorrhage following vaginal delivery. J Obstet Gynaecol Res. 2009;35:48-54.
39. Gülmezoglu A, Forna F, Villar J, et al. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews. 2007;3.
40. Van Selm M, Kahnai H, Keirse M. Preventing the recurrence of atonic postpartum hemorrhage: a double-blind trial. Acta Obstet Gynecol Scand. 1995;14: 270-274.
41. Nellore V, Mittal S, Dadhwal V. Rectal misoprostol versus 15-methyl prostaglandin F2-alpha for the prevention of postpartum hemorrhage. International Journal of Gynecology & Obstetrics. 2006; 94:45-46.
42. Catanzarite VA. Prophylactic intramyometrial carboprost tromethamine does not substantially reduce blood loss relative to intramyometrial oxytocin at routine cesarean section. Am J Perinatol 1990;7:39-42.
43. Chou M, MacKenzie I. A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15- methyl prostaglandin F2 alpha, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section. Am J Obstet Gynecol. 1994;171:1356-1360.
44. Khan R, El-Refaey H, Sharma S, et al. Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstet Gynecol. 2004;103:866-870.
45. Khan R, El-Refaey H. Pharmacokinetics and Adverse-Effect Profile of Rectally Administered Misoprostol in the Third Stage of Labor. Obstet Gynecol. 2003; 101:968-974.
46. Zieman M, Fong S, Benowitz N, et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:88-92.
47. Tang O, Schweer H, Seyberth H, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 2002;17:332-336.
48. Meckstroth K, Whitaker A, Bertisch S, et al.Misoprostol administered by epithelial routes: drug absorption and uterine response. Obstet Gynecol. 2006;108:582-590.
49. Hofmeyr J, Walraven G, Gülmezoglu A, et al. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG. 2005;112:547-553.
50. Gülmezoglu A, Villar J, Ngoc N, et al. WHOmulticentre randomised trial of misoprostol in the management of the third stage of labour. Lancet. 2001;358:689-695.
51. Villar J, Gülmezoglu A, Hofmeyr J. Systematic Review of Randomized Controlled Trials of Misoprostol to Prevent Postpartum Hemorrhage. Obstet Gyn. 2002;100:1301-1312.
52. Baskett T, Persad V, Clough H, et al. Misoprostol versus oxytocin for the reduction of postpartum blood loss. Int J Gynecol Obstet. 2007;97:2-5. (Pubitemid 46349046)
53. Parsons S, Walley R, Crane J, et al. Rectal misoprostol versus oxytocin in the management of the third stage of labour. J Obstet Gynaecol Can 2007;29:711-718.
54. Nasr A, Shahin A, Elsamman A, et al. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage. Int J Gynaecol Obstet. 2009; 105:244-247.
55. Derman RJ, Kodkany BS, Goudar SS, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet. 2006;368:1248-1253.
56. Bradley S, Prata N, Young-Lin N, et al. Cost-effectiveness of misoprostol to control postpartum hemorrhage in low-resource settings. Int J Gynecol and Obstet. 2007;97:52-56.
57. Vimala N, Mittal S, Kumar S, et al. Sublingual misoprostol versus methylergometrine for active management of the third stage of labor. Int J Gynaecol Obstet. 2004;87:1-5.
58. Amant F, Spitz B, Timmerman D, et al. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial. Br J Obstet Gynaecol. 1999;106: 1066-1070.
59. Chongsomchai C, Lumbiganon P, Laopaiboon M. Prophylactic antibiotics for manual removal of retained placenta in vaginal birth. Cochrane Database of Systematic Reviews. 2006;2.
60. O'Brien P, El-Refaey H, Gordon A, et al. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocine and ergometrine: a descriptive study. Obstet Gynecol. 1998;92:212-214.
61. Abdel-Aleem H, El-Nashar I, Abdel- Aleem A. Management of severe postpartum hemorrhage with misoprostol. International Journal of Gynecology & Obstetrics. 2001;72:75-76.
62. Peyser R, Kupferminc M. Management of severe postpartum hemorrhage by intrauterine irrigation with prostaglandin E2. Am J Obstet Gynecol. 1990;162:694-696.
63. Kupferminc M, Gull I, Bar-Am A, et al. Intrauterine irrigation with prostaglandin F2-alpha for management of severe postpartum hemorrhage. Acta Obstet Gynecol Scand. 1998;77:548-550.
64. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews. 2007;1.
65. Alexander J, Thomas PW, Sanghera J. Treatments for secondary postpartum haemorrhage. Cochrane Database of Systematic Reviews. 2002;1.
66. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combatsupport hospital. Journal Trauma Inj Infect. 2007;63:805-813.
67. Sperry JL, Ochoa JB, Gunn SR, et al. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma. 2008;65:986-993.
68. Cotton BA, Au BK, Nunez TC, et al. Predefined massive transfusion protocols are associated with a reduction in organfailure and postinjury complications. J Trauma. 2009;66:41-48. [discussion 48-9].
69. Snyder CW, Weinberg JA, McGwinGJr, et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma. 2009;66: 358-362. [discussion 362-4].
70. Padmanabhan A, Schwartz J, Spitalnik S. Transfusion Therapy in Postpartum. Hemorrhage Semin Perinatol. 2009;33: 124-127.
71. Searle E, Pavord S, Alfirevic Z. Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol. 2008;22:1075-1088.
72. Hossain N, Shamsi T, Haider S, et al. Use of recombinant activated factor VII for massive postpartum hemorrhage. Acta Obstet Gynecol Scand. 2007;29:1-7. [Epub ahead of print]
73. Dabelea V, Schultze P, McDuffie R. Intrauterine Balloon Tamponade in the Management of Postpartum Hemorrhage. Am J Perinatol. 2007;24:359-364.
74. Doumouchtsis S, Papageorghiou A, Vernier C, et al. Management of postpartum hemorrhage by uterine balloon tamponade: Prospective evaluation of effectiveness Acta Obstet et Gynecol Scand. 2008; 87:849-855.
75. Doumouchtsis S, Papageorghiou A, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gyn Surv. 2007;62: 540-547.
76. Lynch C, Coker A, Lawal A, et al. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol. 1997;104: 372-375.
77. Winogard R. Uterine artery embolization for postpartum hemorrhage. Best Pract Res Clin Obstet Gyn. 2008;22:1119-1132.
78. Hansch E, Chitkara U, McAlpine J, et al. Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol. 1999;180: 1454-1460.
79. Vegas G, Illescas T, Muñoz M, et al. Selective pelvic arterial embolization in the management of obstetric hemorrhage. Eur J Obstet Gynecol Reprod Biol. 2006;127:68-72. [Epub 2005 Oct 17].
80. Sentilhes L, Gromez A, Trichot C, et al. Fertility after B-Lynch suture and stepwise uterine devascularization. Fertil Steril. 2009;91:934.e5-934.e9. [Epub 2008 Nov 8]
81. Wang H, Garmel S. Successful term pregnancy after bilateral uterine artery embolization for postpartum hemorrhage. Obstet Gynecol. 2003;102:603-604.
82. Chauleur C, Fanget C, Tourne G, Levy R, et al. Serious primary postpartum hemorrhage, arterial embolization and future fertility: a retrospective study of 46 cases. Hum Reprod. 2008; 23:1553-1559. [Epub 2008 May 6].
83. Sullivan I, Faulds J, Ralph C. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section. Br J Anaesth. 2008;101:225-229. [Epub 2008 May 30].
84. Allam J, Cox M, Yentis S. Cell salvage in obstetrics. Int J Obstet Anesth. 2008;17: 37-45.